Preventing fragility hip fracture in high risk groups: An opportunity missed

Postgraduate Medical Journal

Volumn 82, Issue 970, 2006, Pages 528-531

  Peng, E W K ^b   Elnikety, S ^b   Hatrick, N C ^a,b  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b Worthing Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG USE; EARLY MENOPAUSE; FALLING; FRAGILITY FRACTURE; GENERAL PRACTITIONER; HIP FRACTURE; HUMAN; HYPOGONADISM; INTERPERSONAL COMMUNICATION; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OSTEOLYSIS; OSTEOPOROSIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; FEMALE; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33747498374     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.044370     Document Type: Article

References (18)

1. Royal College of Physicians and Bone and Tooth Society of Great Britain. Osteoporosis - Clinical guidelines for prevention and treatment: update on pharmacological interventions and algorithm for management. London: RCP/BTSCB, 2001.
2. National Osteoporosis Society (UK). Primary care strategy for osteoporosis and falls. London: NOS, 2002.
3. Woolf AD, Akesson K. Preventing fractures in elderly people. BMJ 2003;327:89-95.
4. The Brighton and Hove Fracture Prevention and Osteoporosis Steering Group. Osteoporosis care pathway. Brighton: The Brighton and Hove Fracture Prevention and Osteoporosis Steering Group, 2003.
5. Cummings SR, Melton U. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-7.
6. Brighton and Sussex University Hospitals NHS Trust. Annual Report 2002/2003. Brighton: Brighton and Sussex University Hospitals NHS Trust, 2003.
7. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348:1535-41.
8. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the fracture intervention trial. JAMA 1998;280:2077-82.
9. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopousal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-45.
10. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257-64.
11. Harwood RH, Sahota O, Gaynor K, et al. The Nottingham neck of femur (NONOF) study. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham neck of femur (NONOF) study, Age Ageing 2004;33:45-51.
12. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51.
13. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721-39.
14. Lindsay R. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980;i:1152-4.
15. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial, JAMA 2002;288:321-33.
16. Stephen LJ, McLellan AR, Harrison JH, et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999;8:339-42.
17. Kanis J, Johnell O, Gullberg B, et al. Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean osteoporosis study. Osteoporos Int 1999;9:45-54.
18. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-73.